Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 6 results.
User Information
Export Records
  1. 1.   Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy
  2. Wilkinson, Scott; Ye, Huihui; Karzai, Fatima; Harmon,Stephanie; Terrigino, Nicholas T; VanderWeele, David J; Bright, John R; Atway, Rayann; Trostel, Shana Y; Carrabba, Nicole V; Whitlock, Nichelle C; Walker, Stephanie M; Lis, Rosina T; Abdul Sater, Houssein; Capaldo, Brian J; Madan, Ravi A; Gulley, James L; Chun, Guinevere; Merino, Maria J; Pinto, Peter A; Salles, Daniela C; Kaur, Harsimar B; Lotan, Tamara L; Venzon, David J; Choyke, Peter L; Turkbey, Baris; Dahut, William L; Sowalsky, Adam G
  3. European Urology. 2021, Dec; 80(6): 746-757.
  1. 2.   Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [F-18]DCFPyL PET Imaging
  2. Roy, Jyoti; White, Margaret E.; Basuli, Falguni; Opina, Ana Christina L.; Wong, Karen; Riba, Morgan; Ton, Anita T.; Zhang, Xiang; Jansson, Keith H.; Edmondson,Elijah; Butcher,Donna; Lin, Frank I.; Choyke, Peter L.; Kelly, Kathleen; Jagoda, Elaine M.
  3. Molecular Imaging and Biology. 2021, Oct; 23(5): 745-755.
  1. 3.   Therapeutic Potential of Leelamine, a Novel Inhibitor of Androgen Receptor and Castration-Resistant Prostate Cancer
  2. Singh, Krishna B.; Ji,Xinhua; Singh, Shivendra V.
  3. MOLECULAR CANCER THERAPEUTICS. 2018, Oct; 17(10): 2079-2090.
  1. 4.   Gossypol Induces Apoptosis by Activating p53 in Prostate Cancer Cells and Prostate Tumor-Initiating Cells
  2. Volate, S. R.; Kawasaki, B. T.; Hurt, E. M.; Milner, J. A.; Kim, Y. S.; White, J.; Farrar, W. L.
  3. Molecular Cancer Therapeutics. 2010, Feb; 9(2): 461-470.
  1. 5.   Stem cells in prostate cancer - Resolving the castrate-resistant conundrum and implications for hormonal therapy
  2. Sharifi, N.; Kawasaki, B. I.; Hurt, E. M.; Farrar, W. L.
  3. Cancer Biology & Therapy. 2006, Aug; 5(8): 901-906.
  1. 6.   Molecular alterations in primary prostate cancer after androgen ablation therapy
  2. Best, C. J. M.; Gillespie, J. W.; Yi, Y. J.; Chandramouli, G. V. R.; Perlmutter, M. A.; Gathright, Y.; Erickson, H. S.; Georgevich, L.; Tangrea, M. A.; Duray, P. H.; Gonzalez, S.; Velasco, A.; Linehan, W. M.; Matusik, R. J.; Price, D. K.; Figg, W. D.; Emmert-Buck, M. R.; Chuaqui, R. F.
  3. Clinical Cancer Research. 2005, OCT 1; 11(19, Part 1): 6823-6834.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel